Price T Rowe Associates Inc Atri Cure, Inc. Transaction History
Price T Rowe Associates Inc
- $836 Billion
- Q2 2024
A detailed history of Price T Rowe Associates Inc transactions in Atri Cure, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 39,858 shares of ATRC stock, worth $1.5 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
39,858
Previous 32,202
23.77%
Holding current value
$1.5 Million
Previous $980,000
7.35%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ATRC
# of Institutions
205Shares Held
48.3MCall Options Held
111KPut Options Held
23.8K-
Vanguard Group Inc Valley Forge, PA4.62MShares$174 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.62MShares$174 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY4.2MShares$158 Million0.03% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT2.67MShares$101 Million0.39% of portfolio
-
Macquarie Group LTD Australia, C32MShares$75.2 Million0.05% of portfolio
About AtriCure, Inc.
- Ticker ATRC
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 46,424,700
- Market Cap $1.75B
- Description
- AtriCure, Inc. develops, manufactures, and sells devices for the surgical ablation of cardiac tissue and systems, and intercostal nerves to medical centers in the United States, Europe, Asia, and internationally. The company offers Isolator Synergy Clamps, a single-use disposable radio frequency products; multifunctional pens and linear ablation...